Buprenorphine and Medication Management in a Community Corrections Population

Cropsey, Karen L.; Lane, Peter S; Perkins, Adam; Clark, C. Brendan; Hardy, Sonya; McCullumsmith, Cheryl B.; Stitzer, Maxine L.

doi:10.1097/adm.0b013e31828e6b21

Cited by 11 publications

(6 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Lind et al (2005) found that for every 100 females under 30yrs on an OST programme for one year there was a reduction of 44 charges overall (with 27 for women over 30 yrs and 10 for men) (p=<0.0001). Less positive results were found by Cropsey et al (2011Cropsey et al ( & 2013. Whilst DUWOs receiving buprenorphine to aid relapse prevention participated in and completed treatment at a significantly higher rate than the placebo group (p=<0.0001); on 3 month follow up there were no difference with 83% of both groups having a positive urine opiate screen.…”

Section: Opiate Substitution Therapymentioning

confidence: 82%

Effective interventions for drug using women offenders: A narrative literature review

Grace

2017

Journal of Substance Use

View full text Add to dashboard Cite

A detailed understanding of the effectiveness of interventions designed to meet drug using women offenders' (DUWOs) complex needs is essential to maximise success. This article reports on a narrative literature review of evaluations of interventions designed to assist DUWOs in their recovery from drug use and in their desistance from offending. It aims to identify gaps in that research and point to possible directions for future studies. It shows that successful interventions are likely to be intensive, of significant duration, multi-dimensional and inter-disciplinary. Evaluations must similarly be designed to take into account all individual and structural factors. Qualitative longitudinal research which incorporates DUWOs' opinions on their needs might best inform the development of interventions tailored to meeting those needs. Evaluation design should acknowledge the importance of progress as well as outcomes and be designed to follow DUWOs through their whole sentence rather than focusing on a single intervention/point in time without the context of what came before and what might or should happen in the future.

show abstract

Section: Opiate Substitution Therapymentioning

confidence: 82%

Effective interventions for drug using women offenders: A narrative literature review

Grace

2017

Journal of Substance Use

View full text Add to dashboard Cite

show abstract

“…The feasibility and acceptability of providing buprenorphine treatment at a community corrections site in Alabama was examined by Cropsey and colleagues (2013). This pilot study was conducted with 30 men and women with opioid dependence who were on parole, probation, or drug court supervision.…”

Section: Resultsmentioning

confidence: 99%

“…That study found no difference in illicit opioid or cocaine use, or incarceration over a 6-month post-treatment entry follow-up. The only other reports were longitudinal cohort studies of patients on parole or probation receiving buprenorphine treatment without a comparison group (Cropsey, et al, 2013; Gordon, et al, 2015) that found significant pre-treatment to 3-month follow-up reduction in illicit opioid use and in self-reported criminal behavior (Gordon, et al, 2015) and a significant reduction in drug injection but not in opioid positive urine tests from baseline to short-term follow-up (Cropsey, et al, 2013). These limited data support the use of buprenorphine through drug treatment programs for individuals under community supervision.…”

Section: Resultsmentioning

confidence: 99%

Pharmacotherapy for opioid addiction in community corrections

Schwartz

Mitchell

O’Grady

et al. 2018

International Review of Psychiatry

View full text Add to dashboard Cite

Pharmacotherapy for opioid addiction with methadone, buprenorphine, and naltrexone has proven efficacy in reducing illicit opioid use. These treatments are underutilized among opioid-addicted individuals on parole, probation or in drug courts. This paper examines the peer-reviewed literature on the effectiveness of pharmacotherapy for opioid addiction of adults under community-based criminal justice supervision in the US. Compared to general populations, there are relatively few papers addressing the separate impact of pharmacotherapy on individuals under community supervision. Tentative conclusions can be drawn from the extant literature. Reasonable evidence exists that illicit opioid use and self-reported criminal behavior decline after treatment entry and that these outcomes are as favorable among individuals under criminal justice supervision as the general treatment population. Surprisingly, there is no conclusive evidence regarding the extent to which pharmacotherapy impacts the likelihood of arrest and incarceration among individuals under supervision. However, given the proven efficacy of these three medications in reducing illicit opioid use and the evidence that in the general population, methadone and buprenorphine treatment are associated with reduction in overdose mortality, the use of all three pharmacotherapies among patients under criminal justice supervision should be expanded while more data are collected on their impact on arrest and incarceration.

show abstract

“…We are aware of only three published studies in the US of buprenorphine pharmacotherapy treatment of OUD in community corrections populations. [24][25][26] Moreover, none of these studies systematically examined the impact of co-location of buprenorphine treatment services at the community criminal justice supervision office. However, these studies did demonstrate the feasibility, acceptability, and effectiveness of treating individuals in community supervision with buprenorphine.…”

Section: Buprenorphine Pharmacotherapy With Community Corrections Populationsmentioning

confidence: 99%

A randomized controlled trial of buprenorphine for probationers and parolees: Bridging the gap into treatment

Gordon

Vocci

Taxman

et al. 2019

Contemporary Clinical Trials

View full text Add to dashboard Cite

Background: Buprenorphine can be effective in a variety of community substance use treatment settings outside of methadone programs, including outpatient programs and medical practices. In these settings, it has been found to be effective in reducing opioid use and retaining patients in treatment. Despite its effectiveness and safety, it is rarely provided to individuals with opioid use disorders in probation and parole settings.Methods.-Male and female individuals under probation or parole supervision (N=320) with histories of opioid use disorder will be enrolled in this randomized controlled trial. Participants will be randomized to one of two study arms: Buprenorphine Bridge Treatment (BBT):Participants will begin buprenorphine using the MedicaSafe dispensing device immediately after an on-site intake at a community supervision office and continue such treatment until they are transitioned to a community program; or Treatment as Usual (TAU): Participants will receive a referral to buprenorphine pharmacotherapy treatment in the community. Treatment outcomes will be: (a) illicit opioid oral saliva drug test results; and (b) treatment adherence (i. entered community based treatment; ii. number of days receiving opioid treatment).Results.-We describe the background and rationale for the study, its aims, hypotheses, and study design.Conclusions.-If shown to increase compliance rates with conditions of probation and parole, buprenorphine treatment co-located at community supervision field offices could have a major impact on delivery of buprenorphine treatment to the criminal justice population. The public health impact of the proposed study would be widespread because this intervention could be implemented throughout areas of the US.

show abstract

Buprenorphine and Medication Management in a Community Corrections Population

Cited by 11 publications

References 25 publications

Effective interventions for drug using women offenders: A narrative literature review

Effective interventions for drug using women offenders: A narrative literature review

Pharmacotherapy for opioid addiction in community corrections

A randomized controlled trial of buprenorphine for probationers and parolees: Bridging the gap into treatment

Contact Info

Product

Resources

About